Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins

Wednesday, February 3, 2010 General News
Email Print This Page Comment
Font : A-A+



MAPLE GROVE, Minn., Feb. 2 Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins. The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.(1)

DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development.(2,3) Vitamin D is an essential vitamin for mom's and baby's skeletal health.(4)

"PreNexa® is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market. This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.

The NDC number for the new formulation of PreNexa® is 0245-0177-30. Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.

Important Safety Information

Please see full Prescribing Information for a complete list of warnings and precautions. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

About Upsher-Smith

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers. Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment. For additional information about PreNexa®, visit www.prenexa.com, or to learn more about Upsher-Smith, visit www.upsher-smith.com.

References

(1) PreNexa (package insert). Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.

(2) Medline Plus. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patientfishoil.html. Accessed September 9, 2008.

(3) Koletzko, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy; review of current knowledge and consensus recommendations. J Perinat Med 36 (2008)5-14.

(4) Mulligan ML, Felton SK, Riek AE, et al. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2009;201.

SOURCE Upsher-Smith Laboratories, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook